Related Experiment Video

Updated: Jul 4, 2026

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

12.3K

Monoclonal Gammopathy of Undetermined Significance

Majdolen Istaiti1, Ola Landgren2, Ari Zimran3

  • 1Amsterdam University Medical Center, Amsterdam.

The New England Journal of Medicine
|December 30, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.2K
Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.6K

Related Experiment Videos

Last Updated: Jul 4, 2026

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

12.3K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.2K
Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.6K

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Articles linked to this work by shared authors, journal, and citation graph.

Sex-Specific Association of Rasagiline with Motor Progression in GBA1-Associated Parkinson's Disease.

Life (Basel, Switzerland)·2026

Glucosylsphingosine (Lyso-Gb1) Dynamics in Untreated States in Gaucher Disease.

International journal of molecular sciences·2026

Improvement of Bone Mineral Density in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: Results from Clinical Studies.

Journal of clinical medicine·2026

MyGauchTM: a patient-centered digital health app for Gaucher disease.

mHealth·2025

A large long-term database of Gaucher disease patients demonstrates increased risk of lymphoma and myeloma, but not of solid tumours.

Internal medicine journal·2025

Effect of Exposure to Enzyme Replacement Therapy on Bone Mineral Density in Children With Gaucher Disease.

Journal of inherited metabolic disease·2025

Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis.

The New England journal of medicine·2026

Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.

The New England journal of medicine·2026

Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk.

The New England journal of medicine·2026

Eplontersen for Transthyretin Amyloid Cardiomyopathy.

The New England journal of medicine·2026

Myeloproliferative Neoplasms.

The New England journal of medicine·2026

B-cell depletion therapy in systemic lupus erythematosus: emerging strategies and challenges.

Expert opinion on biological therapy·2026

68Ga-FAPI PET/CT for assessing fibroblast activation and disease activity in primary Sjögren's disease: a prospective case-control study.

Rheumatology (Oxford, England)·2026

Rheumatoid arthritis flares and de novo inflammatory arthritis after immune checkpoint inhibitor therapy: a single-center exploratory study of clinical phenotypes.

Immunological medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us